CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

RBC Cuts Price Target on Biogen to $256 From $260, Keeps Outperform Rating

Neutral
AI Analysis

Summary

RBC Capital Markets reduced its price target on Biogen from $260 to $256 while maintaining an Outperform rating.

Importance:2/10
Sentiment:
-0.10
price_target_cutequity_researchanalyst_rating
Related Companies

Read the original article

Published by yahoo_finance on October 8, 2026 11:05 AM

Read Original